DiscernDx
DiscernDx is a healthcare technology company based in Palo Alto, California, founded in 2017. It operates an online platform that provides users with access to individualized clinical and molecular data, enabling proactive health management and informed decision-making. The platform leverages artificial intelligence and machine learning to detect, measure, and interpret signals from the body, facilitating early disease detection and personalized care. By focusing on the earliest indicators of developing diseases as well as existing conditions, DiscernDx aims to improve health outcomes and transform the healthcare experience for individuals.
Applied Proteomics
Acquisition in 2018
Applied Proteomics, Inc. is a diagnostics company based in San Diego, California, founded in 2006. The company specializes in developing noninvasive, blood-based tests aimed at monitoring and early detection of diseases through protein biomarkers. Its flagship product, the SimpliPro Colon test, exemplifies its approach to diagnostics. By leveraging a proteomics platform, Applied Proteomics focuses on creating innovative molecular diagnostic tools that facilitate the discovery of protein-based biomarkers. This technology enables healthcare providers to assess the proteome's current status, acting as an early-warning system for various diseases. The company's advancements in proteomics are directed toward enhancing personalized medicine and improving overall healthcare outcomes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.